Puneet Souda
Stock Analyst at Leerink Partners
(1.59)
# 3,420
Out of 5,008 analysts
216
Total ratings
49.14%
Success rate
-0.89%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $70 → $75 | $64.14 | +16.93% | 6 | Sep 25, 2025 | |
| CYRX Cryoport | Upgrades: Outperform | $16 | $10.12 | +58.18% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $9.06 | +32.45% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $5.94 | +34.68% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $9.17 | -1.85% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $67.49 | +11.14% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $7.83 | +168.37% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $35.18 | +13.70% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $171.14 | -12.35% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $328.33 | +14.21% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $630 | $544.20 | +15.77% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $23.25 | +50.52% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $141.67 | +2.35% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $209.12 | +43.46% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $97.51 | +156.38% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $60.58 | +81.58% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $58.45 | +28.31% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $148.67 | +34.53% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $6.00 | +200.25% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.67 | +260.36% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $33.26 | -9.80% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $35.33 | +146.25% | 13 | May 5, 2022 |
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $70 → $75
Current: $64.14
Upside: +16.93%
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $10.12
Upside: +58.18%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $9.06
Upside: +32.45%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $5.94
Upside: +34.68%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $9.17
Upside: -1.85%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $67.49
Upside: +11.14%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $7.83
Upside: +168.37%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $35.18
Upside: +13.70%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $171.14
Upside: -12.35%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $328.33
Upside: +14.21%
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $544.20
Upside: +15.77%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $23.25
Upside: +50.52%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $141.67
Upside: +2.35%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $209.12
Upside: +43.46%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $97.51
Upside: +156.38%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $60.58
Upside: +81.58%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $58.45
Upside: +28.31%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $148.67
Upside: +34.53%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $6.00
Upside: +200.25%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.67
Upside: +260.36%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $33.26
Upside: -9.80%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $35.33
Upside: +146.25%